JPRN-UMIN000018997已完成未知
The Sodium glucose transporter 2 inhibitor with acute insulin treatment for controlling severe hyperglycemia in patients with type 2 Diabetes mellitus - The Sodium glucose transporter 2 inhibitor with acute insulin treatment for controlling severe hyperglycemia in patients with type 2 Diabetes mellitus
Toho University School of Medicine,Divsion of diabetes, metabolism and endocrinology0 个研究点目标入组 20 人开始时间: 2015年9月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Type 1 diabetes mellitus patients or secondary diabetic mellitus (2) Patients who had myocardial infarction within 3 months, or obvious heart failure case (3) Patients who had the past of hypersensitivity for the used drug (4) Patients with diabetic ketoacidosis or diabetic coma or risk of diabetic coma (5) Patients with severe liver disease (6) Patients with severe renal disease (7) Patients with severe pancreas disease (8) Patients with hemoglobin (Hb) less than 11 g/dL (9) Patient during cancer treatment (10) Patients that the number of the platelets is less than 100,000 /mm3 (11) Patients with high diabetic neuropathy (12) Patients having a proliferative retinopathy (13) Patients with a serious infectious disease or a serious injury (14) Excessive common custom drinker (15) A pregnant woman or the woman who may be pregnant (16) In addition, the patient who judged inappropriate by an attendant physician
研究者
相似试验
进行中（未招募）
1 期
A comparison of two drugs for treating patients with Chronic Kidney Disease and protein in the urineChronic Kidney Disease with albuminuriaMedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2022-000740-29-DKDepartment of Renal Medicine, Aarhus University Hospital20
招募中
3 期
Empagliflozin in stage 4 non-diabetic kidney diseaseChronic kidney diseaseACTRN12622001371785niversity of Otago6
招募中
1 期
SOdium-Glucose cotransporter 2 inhibitor, ALDosterone AntagonIst, or both for heart failure with Preserved Ejection Fraction: a two-centre randomised three-treatment three-period crossover trialHeart Failure with Preserved Ejection FractionMedDRA version: 20.1Level: LLTClassification code 10076396Term: Heart failure with preserved ejection fractionSystem Organ Class: 100000004849EUCTR2020-000973-26-PTFaculdade de Medicina da Universidade do Porto108
已完成
不适用
Sodium glucose cotransporter inhibitor 2, Tofogliflozin versus glimepiride, comparative trial in Patients with type 2 diabetes On Body composition (STOP-OB study)Type 2 DiabetesJPRN-UMIN000026161Japan society for Patient Reported Outcome64
已完成
1 期
Effects of sodium glucose co-transporter-2 inhibitor on atrial arrhythmia burden in patient with cardiovascular implantable electronic device: a randomized controlled trialAtrial fibrillation in patients with cardiac implantable electronic deviceTCTR20210315003Faculty of Medicine, Chiang Mai University166